The Disability Income Protection insurance plan from FGII is a...
Category:
Non-Life
Latest
High temperature disrupts flights to high altitude Leh airport
The maximum temperature at which an A320 Neo aircraft can operate...
CrowdStrike: Delta Air to seek compensation over IT outage
The cyber outage led to more than 2,200 flight cancellations on...
Hybrid SIRC planned in 2021, Current EC of Singapore Reinsurers’ Association re-elected for 2021-22
“With the global roll-out of the COVID-19 vaccines, we are cautiously optimistic that by the time the 17th SIRC is staged in November, some of the Safe Management Measures and travel restrictions that are currently in place will be eased so that we can welcome some of our loyal international supporters back to our shores. Hence, our Secretariat is already drawing up plans for a ‘hybrid event’, combining a virtual segment similar to the SIRC 2020 Re-Mind event that was organised last year, with a scaled-down ‘live event’ that will incorporate all health and safety protocols aligned with the prevailing SMMs mandated by the relevant authorities.”Marc Haushofer, Chief Executive Officer, Asia Pacific & Executive Vice President of Validus Reinsurance Company, who has also been reelected as the SRA Chairman, for 2021-2022
9 months after lockdowns, US births see biggest decline since 1973
Coupled with the more than half a million Americans who have died from Covid-19, the drop in births will have long-term consequences for the population growth.
Delta variant ‘greatest threat’ to US’ COVID-19 efforts: Dr Fauci
”Similar to the situation in the UK, the Delta variant is currently the greatest threat in the US to our attempt to eliminate COVID-19,” Fauci told reporters during a virtual news conference here.
However, the “good news” is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases (NIAID).
Private hospitals to log 15-17% revenue growth in FY22: Crisil
“While the second wave lashed again in April, the first quarter this fiscal will be sharply better on-year, with occupancy of 75 per cent, almost double on-year. This will be largely on account of a surge in Covid-19 treatments more than offsetting the deferral of elective surgeries and outpatient footfalls,” Crisil Ratings Senior Director Manish Gupta said.
As the second wave recedes in the second quarter, Crisil expects pent-up demand for non-Covid treatments to rebound and support occupancy, he added.
IRDAI allows home treatment as add-on cover in health insurance
Reacting to the development, Liberty General Insurance Ltd’s CEO and Whole Time Director Roopam Asthana told IANS that the “add-on cover has to be priced right taking into account the data and possible scenarios”.
Though the insurers will save on huge daily hospital room charges, the doctor and nurse fee may be on slightly on the higher side then what a hospital charges.
World Bank, African Union join forces to expand access to Covid-19 vaccines
Strive Masiyiwa, African Union special envoy, said the collaboration between the World Bank and African institutions such as the Africa Import Export Bank and the Africa Centre for Disease Control would provide the capacity to vaccinate at least 400 million people or 30% of the total African population.
SC reserves verdict on Rs 4 lakh ex-gratia compensation to kin of COVID-19 deceased
The top court asked the parties to file written submissions in three days and specifically directed the Centre to simplify the process of grant of death certificates to the dependents of those who have died of COVID-19.
The Centre had earlier told the apex court that the ex-gratia compensation of Rs 4 lakh cannot be paid to the families of those who have died of COVID-19 as the finances of state governments and the Centre are under severe strain.
‘If there is any fatality, we will hold state govt responsible’, SC tells AP
“You will have to give very good reasons to hold Class 12 board examinations. If there is any fatality, we will hold the state responsible,” the bench told counsel for Andhra Pradesh.
India reports around 40 cases of Delta plus variant
“As of now among the samples sequenced (45000+) in India, Delta plus variant — AY.1 –has been observed sporadically in Maharashtra, Kerala and Madhya Pradesh, with around 40 cases identified so far and no significant increase in prevalence,” the ministry said in its statement.
These three states have been advised to strengthen surveillance and take appropriate public health measures.
AstraZeneca Plc’s COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.
The study by the Oxford University investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the Delta and Kappa variants, the statement said.
New universal coronavirus vaccine may help prevent the next pandemic
To prevent a future coronavirus pandemic, the team designed the vaccine to provide protection from the current SARS-CoV-2 coronavirus and a group of coronaviruses known to make the jump from animals to humans.